Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Emerson Electric Co. (EMR) vs Tempus AI (TEM) Price & Performance

Emerson Electric Co.Trade
Tempus AITrade

Price performance (Past 24H)

Key statistics

Emerson Electric Co. vs Tempus AI — how do they compare? Emerson Electric Co. trades at $137.59 (market cap $76.31B), while Tempus AI trades at $53.25 (market cap $10.28B). The key difference: Emerson Electric Co. is far larger — about 7.4× Tempus AI's market cap, and Emerson Electric Co. pays a 1.63% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

EMRTEM
Market Cap
$76.31B$10.28B
Sector
IndustrialsBroad Market / Factor
52-Week High
$161.69$103.25
52-Week Low
$123.30$42.37
Enterprise Value
$88.58B$10.96B
Dividend Yield
1.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Emerson Electric Co.

Emerson Electric (EMR) trades at $137.06, up 0.7% on the day, with a bearish technical signal but strong analyst support. Recent earnings have mostly beaten expectations, with Q2 2026 results pending. The company maintains solid profitability with a 13.35% net income margin and a consensus price target of $157.60, suggesting 15% upside. Cash flow trends show operational strength despite net outflows, and a dividend of $0.56 was recently declared.

EMR presents a mixed outlook: bullish fundamentals and analyst ratings contrast with near-term technical weakness. Investment appeal hinges on earnings execution and sector momentum, while risks include debt levels and market volatility. The stock's valuation at a P/E of 31.54 requires sustained growth to justify further gains.

Tempus AI

Tempus AI (TEM) trades at $53.69, down 8.39% over 24 hours, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth ($1.27B in 2025) and consistent earnings beats, but remains unprofitable with negative net income margins (-22.2%). Recent news highlights AI deployment in healthcare systems and FDA clearances, supporting its data-driven healthcare platform.

The outlook balances high-growth potential in AI healthcare data against persistent profitability challenges. Analyst consensus is bullish with a $68.50 price target, but investors face risks from ongoing cash burn, competitive pressures, and execution hurdles as the company scales its platform toward sustainable margins.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Emerson Electric Co.

Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.

Read more on EMR

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM